4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017519
President and CEO gave up 47,774 shares (to pay taxes)
- President and CEO acquired 114,403 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2021-03-01 | Option exercise | +96,150 | 1,251,948 | D: show line 1 in the form | ||
| Walker Neal President and CEO | 2021-03-01 | Shares withheld for taxes | −39,792 | $24.06 | $957,396 | 1,212,156 | D: show line 2 in the form |
| Walker Neal President and CEO | 2021-03-02 | Option exercise | +18,253 | 1,230,409 | D: show line 3 in the form | ||
| Walker Neal President and CEO | 2021-03-02 | Shares withheld for taxes | −7,982 | $23.25 | $185,582 | 1,222,427 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2021-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +255,800 | 255,800 | D: show line 5 in the form | ||
| Walker Neal President and CEO | 2021-03-01 | Grant or award · Restricted stock units | +73,100 | 73,100 | D: show line 6 in the form | ||
| Walker Neal President and CEO | 2021-03-01 | Option exercise · Restricted stock units | −96,150 | 192,300 | D: show line 7 in the form | ||
| Walker Neal President and CEO | 2021-03-02 | Option exercise · Restricted stock units | −18,253 | 54,762 | D: show line 8 in the form |
Loading xslF345X03/doc4.xml…